CNBC: High hopes ride on marijuana painkillers amid opioid crisis

Client AXIM Biotechnologies featured by Reuters, CNBC, Daily Mail UK and more about their recent clinical development program for treating opioids with cannabinoids.

“There are no U.S. Food and Drug Administration (FDA)-approved painkillers derived from marijuana, but companies such as Axim Biotechnologies Inc, Nemus Bioscience Inc and Intec Pharma Ltd have drugs in various stages of development…

…Rival Axim, whose North American headquarters is in New York, is conducting preclinical studies on a chewing gum containing synthetic CBD and THC, a psychoactive compound found in marijuana. The company expects to submit an FDA application to start a trial on opioid-dependent patients this year.”